Note to our followers: Due to a lack of sufficient funding, will cease daily publication of new content at the end of 2018. Publisher Gary Schwitzer and other contributors may post new articles periodically. If you wish to donate, your gift might help keep the site available to the public for a few more years, by defraying costs of web hosting and maintenance. All of our 6,000+ published articles contain lessons to help people improve their critical thinking about health care. Read more about our change in status. And here's how to make a donation.

Do you write news releases? And want help?
We offer free pre-publication review of releases. SEE MORE →

November 15, 2018 | Story Review

Reuters rehashes Merck announcement on Keytruda trial for esophageal cancer

You can’t do much in a 176-word story, and Reuters didn’t in this one.

1 Star

Reuters: Merck drug Keytruda succeeds in late-stage esophageal cancer trial

November 13, 2018 | Story Review

CNN overstates evidence linking neck pulse measurements to increased dementia risk

The story didn’t tell readers this was an observational study–cause-and-effect couldn’t be established.

2 Star

Five-minute neck scan can spot dementia 10 years earlier, say scientists

November 9, 2018 | Story Review

Fox News regurgitates a hot mess from the UK Sun

The story is full of holes and canned quotes, making the news release more informative.

2 Star

Artificial intelligence can predict Alzheimer’s 6 years earlier than medics, study finds

November 1, 2018 | Story Review

Thoughtful and thorough, AP story looks at growing trend of using ketamine for depression

When it comes to ketamine, people with depression and their families should be informed of the unclear benefits and risks.

5 Star

High hopes & hype for experimental depression drug ketamine

October 29, 2018 | Story Review

ABC News story perpetuates misinformation that new drug will prevent spread of flu

Also, the story states that Xofluza is associated with fewer side effects than Tamiflu, but it doesn’t mention any potential harms.

2 Star

FDA approves new flu pill that can be taken after onset of symptoms

October 29, 2018 | Story Review

New York Times warns readers that new flu drug ‘is no miracle cure’

The story provides people with the fundamental details they need to be informed patients.

4 Star

F.D.A. Approves New Drug for Flu

October 24, 2018 | Story Review

Litany of errors hampers Reuters story on experimental breast cancer drug

The story conflates progression-free survival with overall survival.

2 Star

Novartis drug cut death risk by 35 percent in gene mutation breast cancer

October 21, 2018 | Story Review

HealthDay speculates that experimental cystic fibrosis drug combo could be ‘breakthrough’ and ‘game-changing’

Thankfully, the story did mention the extremely steep cost of these drugs.

3 Star

3-Drug Therapy Might Be Cystic Fibrosis 'Breakthrough'

October 18, 2018 | Story Review

HealthDay touts nerve device as ‘more effective,’ but data is from unpublished study with no control group

But the story did a good job of reporting on the cost and availability of this procedure.

3 Star

New Nerve Stimulation Technique Might Relieve Back Pain

October 16, 2018 | Story Review

Inquirer’s look at using Facebook to screen for depression emphasizes research ‘is still in very early stages’

It would have been helpful if the story had explored who would pay for this kind of screening, and what we know about depression screening in general: Is it effective?

4 Star

Depression often goes undiagnosed. Researchers are turning to Facebook to change that.


Tips & Resources for Analyzing Health Care Claims

View More